Global Plasma Protein Therapeutics Market Size study & Forecast, by Product Type, by Application and Regional Analysis, 2022-2029

Description

List of Tables

Global Plasma Protein Therapeutics Market is valued at approximately USD 27.45 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2022-2029. Plasma protein therapeutics is a biological medicine made up of plasma. It is a biological substance with a distinct chemical composition depending upon how it was produced and processed. The majority of blood is made up of plasma, contains water, salts, proteins, antibodies, and enzymes. The Plasma Protein Therapeutics market is expanding because of factors such as increasing incidence of immune deficiency disorder and surge in geriatric populations. Its prevalence has progressively increased during the last few years.

Plasma protein therapies are used in the treatment of various chronic, life-threatening, and genetic diseases. Its prevalence has progressively increased during the last few years. According to Statista, plasma demand around the world was expected to increase up to 50 million liters by 2020. Furthermore, in 2020, more than 1018.8 metric tons of albumin were consumed worldwide and projected to reach around 1125.5 metric tons by 2022. It is a global protein generated from blood plasma used for cancer diagnostics and therapies, and Morbus Wilson treatments. It is used mostly for cancer diagnostics and therapies. Another important component driving space is increasing geriatric populations. In 2022, Monaco was the country with the highest percentage of total population that was over the age of 65. Monaco has the oldest population in the world with 36 percent of Japanese over 65. Germany on the other hand has 22 percent of its population being over 65 in 2022. In addition Approximately 25% of the world's population is under 15, while 10% is over 65. The youngest population in the world is found in Africa. Indicating the low life expectancy in many nations, 40% of people on the continent are under the age of 15 and less than 4% are over 65. Contrarily, in Europe, a greater proportion of the population is over 65 than is under 15 years old. Furthermore, in 2021 Baxter International Inc. announced the global launch of PrisMax 2. It is designed to simplify delivery of continuous renal replacement therapy and organ support plasma therapies, while providing flexibility to meet the demands of the intensive care unit . The PrisMax 2 system features the company's TrueVue digital health portfolio, as well as the PrismaLung blood-gas exchanger that delivers extracorporeal carbon dioxide removal therapy to support acute respiratory dysfunction. However, the high cost of Plasma Protein Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Plasma Protein Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the dominance of increase in healthcare expenditure. According to Statista, the Health Care segment of north America is projected to reach USD 20.77 billion in 2023 and expected to show an annual growth rate of 12.25% in between 2023 to 2027, resulting in a projected market volume of USD 32.97 billion by 2027.Furthermore, Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing research and development related to plasma protein therapies in the market space.

Major market players included in this report are:

Baxter International
Biotest
CSL Behring
China Biologics
GRIFOLS, S.A.
Kedrion
Octapharma USA, Inc
Shire Plc
Takeda Pharmaceutical Company Ltd
ADMA Biologics, Inc

Recent Developments in the Market:

In April 2020, Kedrion Biopharma collaborated with Kamada Ltd. For manufacturing, development, and distribution of a human plasma-derived Anti-SARS-CoV-2 (COVID-19) polyclonal immunoglobulin (IgG) product as a potential treatment for COVID-19 patients

Global Plasma Protein Therapeutics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product Type, Application, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product Type:

C1 esterase Inhibitors
Albumins
Immunoglobulins
Others

By Application:

Hereditary Angioedema
Hemophilia
Primary Immunodeficiency Disorder
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Plasma Protein Therapeutics Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Plasma Protein Therapeutics Market, by Product Type, 2019-2029 (USD Billion)
- 1.2.3. Plasma Protein Therapeutics Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Plasma Protein Therapeutics Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Plasma Protein Therapeutics Market Dynamics

3.1. Plasma Protein Therapeutics Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing incidence of immune deficiency disorders
  - 3.1.1.2. Surge in geriatric populations
- 3.1.2. Market Challenges
  - 3.1.2.1. High Cost of Plasma Protein Therapeutics
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rising investments in research and development programs by the pharmaceutical companies

Chapter 4. Global Plasma Protein Therapeutics Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Plasma Protein Therapeutics Market, by Product Type

6.1. Market Snapshot
6.2. Global Plasma Protein Therapeutics Market by Product Type, Performance - Potential Analysis
6.3. Global Plasma Protein Therapeutics Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Plasma Protein Therapeutics Market, Sub Segment Analysis
- 6.4.1. C1 esterase Inhibitors
- 6.4.2. Albumins
- 6.4.3. Immunoglobulins
- 6.4.4. Others

Chapter 7. Global Plasma Protein Therapeutics Market, by Application

7.1. Market Snapshot
7.2. Global Plasma Protein Therapeutics Market by Application, Performance - Potential Analysis
7.3. Global Plasma Protein Therapeutics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Plasma Protein Therapeutics Market, Sub Segment Analysis
- 7.4.1. Hereditary Angioedema
- 7.4.2. Haemophilia
- 7.4.3. Primary Immunodeficiency Disorder
- 7.4.4. Others

Chapter 8. Global Plasma Protein Therapeutics Market, Regional Analysis

8.1. Plasma Protein Therapeutics Market, Regional Market Snapshot
8.2. North America Plasma Protein Therapeutics Market
- 8.2.1. U.S. Plasma Protein Therapeutics Market
  - 8.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
  - 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
- 8.2.2. Canada Plasma Protein Therapeutics Market
8.3. Europe Plasma Protein Therapeutics Market Snapshot
- 8.3.1. U.K. Plasma Protein Therapeutics Market
- 8.3.2. Germany Plasma Protein Therapeutics Market
- 8.3.3. France Plasma Protein Therapeutics Market
- 8.3.4. Spain Plasma Protein Therapeutics Market
- 8.3.5. Italy Plasma Protein Therapeutics Market
- 8.3.6. Rest of Europe Plasma Protein Therapeutics Market
8.4. Asia-Pacific Plasma Protein Therapeutics Market Snapshot
- 8.4.1. China Plasma Protein Therapeutics Market
- 8.4.2. India Plasma Protein Therapeutics Market
- 8.4.3. Japan Plasma Protein Therapeutics Market
- 8.4.4. Australia Plasma Protein Therapeutics Market
- 8.4.5. South Korea Plasma Protein Therapeutics Market
- 8.4.6. Rest of Asia Pacific Plasma Protein Therapeutics Market
8.5. Latin America Plasma Protein Therapeutics Market Snapshot
- 8.5.1. Brazil Plasma Protein Therapeutics Market
- 8.5.2. Mexico Plasma Protein Therapeutics Market
- 8.5.3. Rest of Latin America Plasma Protein Therapeutics Market
8.6. Rest of The World Plasma Protein Therapeutics Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. Company Profiles
- 9.2.1. Baxter International
  - 9.2.1.1. Key Information
  - 9.2.1.2. Overview
  - 9.2.1.3. Financial (Subject to Data Availability)
  - 9.2.1.4. Product Summary
  - 9.2.1.5. Recent Developments
- 9.2.2. Biotest
- 9.2.3. CSL Behring
- 9.2.4. China Biologics
- 9.2.5. GRIFOLS, S.A.
- 9.2.6. Kedrion
- 9.2.7. Octapharma USA, Inc
- 9.2.8. Shire Plc
- 9.2.9. Takeda Pharmaceutical Company Ltd
- 9.2.10. ADMA Biologics, Inc

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Plasma Protein Therapeutics Market, report scope
TABLE 2. Global Plasma Protein Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Plasma Protein Therapeutics Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
TABLE 4. Global Plasma Protein Therapeutics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Plasma Protein Therapeutics Market
TABLE 70. List of primary sources, used in the study of global Plasma Protein Therapeutics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Plasma Protein Therapeutics Market, research methodology
FIG 2. Global Plasma Protein Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Plasma Protein Therapeutics Market, key trends 2021
FIG 5. Global Plasma Protein Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Plasma Protein Therapeutics Market, porters 5 force model
FIG 7. Global Plasma Protein Therapeutics Market, pest analysis
FIG 8. Global Plasma Protein Therapeutics Market, value chain analysis
FIG 9. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Plasma Protein Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Plasma Protein Therapeutics Market, company Market share analysis (2021)